Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease

AIM: Children with haematological malignancy represent an identified subgroup of the paediatric population with specific pharmacokinetic parameters. In these patients, inadequate empirical antibacterial therapy may result in infection-related morbidity and increased mortality, making optimization of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Clin Pharmacol
Prif Awduron: Zhao, Wei, Zhang, Daolun, Storme, Thomas, Baruchel, André, Declèves, Xavier, Jacqz-Aigrain, Evelyne
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Ltd 2015
Pynciau:
Paediatric Clinical Pharmacology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631192/
https://ncbi.nlm.nih.gov/pubmed/26138279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12710
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg